Pharmacoeconomics of ocular anti-infective treatments

J. D. Hirsch, Terrence O'Brien

Research output: Contribution to journalArticle

Abstract

Pharmacoeconomic evaluations can provide useful information regarding the comparative value among drug treatments for ocular infections. These analyses estimate the value of the set of outcomes (economic, clinical, and humanistic) that result from one treatment and then systematically compare it to the value offered by the set of outcomes that result from an alternative treatment. Many factors can affect the balance of resources used and outcomes achieved among treatment strategies, such as timing to diagnosis of infection, use and accuracy of test to identify appropriate treatment, prophylaxis versus treatment of infection, and variation in efficacy and safety profiles of therapeutic agents employed. This article describes and presents examples of basic pharmacoeconomic analyses that can be used to enhance the treatment selection process for ocular infections.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalOphthalmology Clinics of North America
Volume12
Issue number1
DOIs
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

Eye Infections
Pharmaceutical Economics
Infection
Economics
Safety
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Pharmacoeconomics of ocular anti-infective treatments. / Hirsch, J. D.; O'Brien, Terrence.

In: Ophthalmology Clinics of North America, Vol. 12, No. 1, 01.01.1999, p. 1-8.

Research output: Contribution to journalArticle

@article{5e6f37603a9f45c38eb3bd5ec4f883b1,
title = "Pharmacoeconomics of ocular anti-infective treatments",
abstract = "Pharmacoeconomic evaluations can provide useful information regarding the comparative value among drug treatments for ocular infections. These analyses estimate the value of the set of outcomes (economic, clinical, and humanistic) that result from one treatment and then systematically compare it to the value offered by the set of outcomes that result from an alternative treatment. Many factors can affect the balance of resources used and outcomes achieved among treatment strategies, such as timing to diagnosis of infection, use and accuracy of test to identify appropriate treatment, prophylaxis versus treatment of infection, and variation in efficacy and safety profiles of therapeutic agents employed. This article describes and presents examples of basic pharmacoeconomic analyses that can be used to enhance the treatment selection process for ocular infections.",
author = "Hirsch, {J. D.} and Terrence O'Brien",
year = "1999",
month = "1",
day = "1",
doi = "10.1016/S0896-1549(05)70143-7",
language = "English (US)",
volume = "12",
pages = "1--8",
journal = "Ophthalmology Clinics of North America",
issn = "0896-1549",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pharmacoeconomics of ocular anti-infective treatments

AU - Hirsch, J. D.

AU - O'Brien, Terrence

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Pharmacoeconomic evaluations can provide useful information regarding the comparative value among drug treatments for ocular infections. These analyses estimate the value of the set of outcomes (economic, clinical, and humanistic) that result from one treatment and then systematically compare it to the value offered by the set of outcomes that result from an alternative treatment. Many factors can affect the balance of resources used and outcomes achieved among treatment strategies, such as timing to diagnosis of infection, use and accuracy of test to identify appropriate treatment, prophylaxis versus treatment of infection, and variation in efficacy and safety profiles of therapeutic agents employed. This article describes and presents examples of basic pharmacoeconomic analyses that can be used to enhance the treatment selection process for ocular infections.

AB - Pharmacoeconomic evaluations can provide useful information regarding the comparative value among drug treatments for ocular infections. These analyses estimate the value of the set of outcomes (economic, clinical, and humanistic) that result from one treatment and then systematically compare it to the value offered by the set of outcomes that result from an alternative treatment. Many factors can affect the balance of resources used and outcomes achieved among treatment strategies, such as timing to diagnosis of infection, use and accuracy of test to identify appropriate treatment, prophylaxis versus treatment of infection, and variation in efficacy and safety profiles of therapeutic agents employed. This article describes and presents examples of basic pharmacoeconomic analyses that can be used to enhance the treatment selection process for ocular infections.

UR - http://www.scopus.com/inward/record.url?scp=0033007108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033007108&partnerID=8YFLogxK

U2 - 10.1016/S0896-1549(05)70143-7

DO - 10.1016/S0896-1549(05)70143-7

M3 - Article

AN - SCOPUS:0033007108

VL - 12

SP - 1

EP - 8

JO - Ophthalmology Clinics of North America

JF - Ophthalmology Clinics of North America

SN - 0896-1549

IS - 1

ER -